Home > Insider Trading > Filing (0001104659-14-040582)

Filing Details

Accession Number:: 0001104659-14-040582
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-21 08:51:15
Reporting Period:: 2014-05-20

Filing Date:: 2014-05-21
Accepted Time:: 2014-05-21 08:51:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1526119	Verastem Inc.	VSTM	Pharmaceutical Preparations (2834)	273269467

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1185039	Richard Aldrich	C/O Verastem, Inc., 215 First Street, Suite 440 Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-20	1,000	$8.37	408,142	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	20,000	Indirect	By Richard H. Aldrich 2005 Revocable Trust
Common Stock	26	Indirect	By Longwood Fund, L.P.
Common Stock	143,554	Indirect	By Longwood Fund GP, LLC
Common Stock	135,714	Indirect	By Richard H. Aldrich Irrevocable Trust of 2011

Footnotes

Reflects change in beneficial ownership pursuant to the partnership agreement of Longwood Fund, L.P.
Longwood Fund GP, LLC is the sole General Partner of Longwood Fund, L.P. Christoph Westphal, M.D., Ph.D., Richard Aldrich and Michelle Dipp, M.D., Ph.D. (collectively, the "Managers") are managers of Longwood Fund GP, LLC, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held by Longwood Fund L.P. (the "Longwood Shares"). Each of the Managers disclaims beneficial ownership of the Longwood Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of the Longwood Shares in this report shall not be deemed an admission of beneficial ownership of the Longwood Shares for purposes of Section 16 or for any other purpose.
Reflects change in beneficial ownership pursuant to the partnership agreement of Longwood Fund, L.P.
Christoph Westphal, M.D., Ph.D., Richard Aldrich and Michelle Dipp, M.D., Ph.D. (collectively, the "Managers") are managers of Longwood Fund GP, LLC, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held by Longwood Fund GP, LLC (the "Longwood GP Shares"). Each of the Managers disclaims beneficial ownership of the Longwood GP Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of the Longwood GP Shares in this report shall not be deemed an admission of beneficial ownership of the Longwood GP Shares for purposes of Section 16 or for any other purpose.